Herings

What Herings does

Herings Co., Ltd. is a Seoul-based digital therapeutics and clinical research company founded in 2016 that operates two interlocking business lines. Its clinical-strategy business delivers oncology-focused trial design, biostatistics, statistical analysis plans (SAP), clinical study report (CSR) writing, and CRO oversight to pharmaceutical clients ranging from early-stage Korean biotechs to global majors; the company reports preferred-vendor relationships with Pfizer, AstraZeneca, Roche, and Merck, and 120+ trials designed/executed with 140+ SCI-level publications (JAMA, NEJM). Its digital health business is a Remote Patient Monitoring (RPM) platform built around the Healiary consumer app for cancer patients, with condition-specific extensions Osto Care and LARS Care for ostomy patients, and ATTI for real-time chemotherapy side-effect monitoring; the platform also supports digital data capture inside clinical trials, as validated in the Seoul National University Hospital NuGa Trial (93.8% user convenience, 95.0% utility).

The platform's underlying technology centers on evidence-based, science-embedded solution algorithms developed from identified pain points in the current medical care system, delivered through a digital service architecture that connects patients to medical professionals across distance and time. Distribution is enterprise-field-sales-led, anchored by a KOL network at Korea's top oncology institutions (National Cancer Center, Seoul National University Hospital, Asan Medical Center, Samsung Medical Center) and supplemented by consumer marketing on Korean social channels (Naver Blog, Kakao, YouTube, Instagram) under the Healiary brand.

Revenue mechanics combine professional-services fees for clinical strategy, biostatistics, and medical writing with subscription-based access to the RPM platform for healthcare providers and patients. The company is founder-led by CEO Nam Byeong-ho, a Boston University PhD in Health Statistics and former National Cancer Center Clinical Research Cooperation Center Director. Recent strategic activity (2024–2026) includes the Healiary app relaunch, an exclusive RPM patent license with Dx&Vx, integration partnerships with InBody and Cirs Technology, a family-care platform partnership with PlanTnet, an EU senior-care MOU with Moving Medicine, and a co-development partnership with La Meditech to build an AI chronic disease management platform.

Name

Herings

Legal name

주식회사 헤링스 (Herings Co., Ltd.)

Website

https://heringsglobal.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Herings is a Seoul-based clinical research and digital therapeutics company that provides oncology-focused trial strategy services and a Remote Patient Monitoring platform (Healiary, Osto Care, ATTI, LARS Care) to pharmaceutical companies, hospitals, and cancer patients.

Ownership category

akta.pro rank

Product category

Digital Health / Remote Patient Monitoring

NAICS

Home Health Care Services (621610), Home Health Care Services (62161)

SIC

Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industries

Care Coordination, Escalation & Clinical Workflow for RPM (HLACAFAI), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

Keywords

• Remote patient monitoring
• Digital therapeutics platform
• Clinical strategy design
• Cancer patient monitoring
• Biostatistics services

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. RPM Platform Subscriptions: Subscription-based access to Remote Patient Monitoring platform services including Healiary app, Osto Care, ATTI, and LARS Care for healthcare providers and patients.
2. Clinical Strategy Services: Professional services for clinical strategy design including endpoint setting, patient population design, statistical design, protocol establishment. CRO oversight services for clinical trial management.
3. Data Analysis & Medical Writing: Biostatistics, Statistical Analysis Plan (SAP), Clinical Study Report (CSR) writing services performed by PhD-level statisticians and professional medical writers.
4. Preferred Vendor Contracts: Preferred vendor contracts with global pharmaceutical companies (Pfizer, AstraZeneca, Roche, Merck) for clinical statistics and data management services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Herings develops and operates a Remote Patient Monitoring (RPM) platform that delivers personalized digital healthcare services for cancer and ostomy patients, including the Healiary app for AI-based diet and symptom management, Osto Care and LARS Care for ostomy care, and ATTI for real-time chemotherapy side effect monitoring. The company also provides clinical strategy design, biostatistics, and medical writing services for pharmaceutical and biotech clients, anchored by preferred vendor relationships with Pfizer, AstraZeneca, Roche, and Merck.

Product overview

Herings is a Remote Patient Monitoring (RPM) platform company that offers personalized healthcare services. The product portfolio includes the core Healiary app for comprehensive healthcare management, along with specialized solutions: Osto Care for ostomy patient care management, ATTI for real-time chemotherapy monitoring, and LARS Care for ostomy patients with personalized bowel pattern management. These products work together to enable doctors and patients to overcome distance barriers and provide therapeutic action through digital healthcare services.

Differentiator

Problem solved

Functional benefit

Brands

• Healiary (힐리어리): AI-powered personalized healthcare platform for cancer patients, providing dietary management and health monitoring services based on bowel patterns and physical response data.
• Osto Care
• ATTI
• LARS Care

Products and services

• Healiary App
• Osto Care
• ATTI
• LARS Care
• Clinical Strategy Design Services
• CRO Oversight Services
• Data Analysis and Medical Writing

Quantifiable outcome

• User convenience 93.8% / Utility 95.0% in NuGa Trial digital healthcare clinical study with Seoul National University Hospital
• +2 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• La MeditechcoreStrategic or Co-development Partner · 18 March 2026Strategic partnership for building AI chronic disease management platform. Collaboration to develop integrated AI-powered solutions for chronic disease management using Herings' remote patient monitoring technology.
• PlanTnetcoreStrategic or Co-development Partner · 9 February 2026Strategic partnership for building family integrated care service platform. Collaboration to create comprehensive family healthcare platform combining both companies' digital health expertise.
• Cirs TechnologycoreStrategic or Co-development Partner · 26 January 2026Strategic partnership expanding to discharge patient monitoring. Herings and Cirs Technology collaborating to extend remote patient monitoring services to post-discharge care, broadening RPM solution coverage.
• Moving MedicinecoreStrategic or Co-development Partner · 24 April 2025Strategic MOU for targeting European senior healthcare market. Partnership to expand Herings' Remote Patient Monitoring solutions to European market, leveraging Moving Medicine's regional expertise and distribution capabilities.
• Dx&VxcoreTechnology or Integration · 13 August 2024Patent exclusive licensing agreement for digital healthcare technology. Dx&Vx granted exclusive implementation rights for digital healthcare patents related to digital health services and remote patient monitoring solutions. Strengthens Herings' intellectual property portfolio in digital healthcare technology.
• InBodycoreStrategic or Co-development Partner · 16 July 2024Strategic partnership for personalized digital healthcare services for cancer patients. Collaboration combines InBody's body composition data with Herings' cancer patient nutrition management solutions. Joint development of customized nutrition solutions based on body composition analysis.
• Boston UniversityminorStrategic or Co-development Partner · 3 May 2024Digital healthcare session collaboration with Boston University related to Remote Patient Monitoring services. Academic partnership leveraging Boston University's health statistics expertise and Herings' CEO background.
• Seoul National University HospitalcoreStrategic or Co-development PartnerCollaborative digital healthcare clinical trial (NuGa Trial). Clinical design, Healiary app-based digital data collection, statistical analysis and paper publication. Resulted in 93.8% user convenience and 95.0% utility scores, successfully validating digital clinical platform.
• Pfizer, AstraZeneca, Roche, MerckcoreChannel Partner/ Reseller/ DistributorPreferred vendor contracts for clinical statistics and data management. Herings serves as preferred vendor for global pharmaceutical companies, providing clinical data management services meeting global quality standards.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Omada Health: Digital therapeutics platform combining RPM and coaching for chronic conditions (diabetes, hypertension, MSK). Comparable in subscription-based digital health delivery, clinical evidence base, and B2B2C go-to-market through payers and employers.
• Welldoc: Digital health company focused on chronic disease (notably diabetes and cardio) RPM with condition-specific AI coaching. Comparable to Herings in evidence-based digital therapeutic positioning, AI personalization, and provider/employer sales channels.
• Belong.Life: Oncology patient engagement and symptom-tracking app used by pharma and providers worldwide. Direct comparable to Herings' Healiary and ATTI in cancer patient RPM, AI-driven personalization, and pharma-sponsored deployment model.
• Vivify Health: Established US-based RPM platform used by health systems and payers for chronic disease and post-acute monitoring. Closely matches Herings' RPM subscription model, device-agnostic architecture, and provider-facing workflows.
• Biofourmis: AI-driven remote patient monitoring and digital therapeutics company covering chronic and post-acute conditions. Comparable to Herings in RPM platform delivery, multi-condition coverage, and enterprise sales to hospitals and pharma.
• Kaiku Health (Noona): Oncology-focused digital symptom monitoring and patient-reported outcomes platform originally a Finnish startup, now part of Elekta. Direct comparable to Herings' ATTI and Healiary RPM offerings for cancer patients undergoing chemotherapy and treatment.

Broad incumbents

• Medtronic Care Management Services: Medtronic's RPM and disease management business offering condition-specific monitoring (cardiac, diabetes, etc.) to providers and payers. Comparable broad incumbent competing with Herings' vertical RPM approach at enterprise scale.
• Philips Remote Patient Monitoring: Global medtech incumbent offering enterprise RPM, telehealth, and chronic care platforms across hospitals. Represents the large-scale incumbent Herings competes against for enterprise RPM contracts in Korea and abroad.

Emerging players

• Navigating Cancer: US oncology patient relationship management and symptom monitoring platform for community oncology practices. Comparable to Herings in oncology-specific patient engagement, RPM workflows, and provider-channel distribution.
• Hicuity Health: US provider of continuous and episodic RPM and tele-ICU services to hospitals. Comparable to Herings in provider-integrated remote monitoring, though Hicuity focuses on acute/post-acute rather than oncology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@healiary
• Instagraminstagram.com/healiary_official
• Xx.com/heringsglobal
• Facebookfacebook.com/heringsglobal
• LinkedInlinkedin.com/company/herings

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Herings